Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

New chemical candidate for treating cocaine addiction

Nov. 3, 1997

New compound isolated from the African tarantula by Neurex

Oct. 31, 1997

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Oct. 29, 1997

Low-molecular-weight selectin inhibitor displays potent antiinflammatory activity

Oct. 27, 1997

NCA-0465: new antitumor indoloquinoxaline derivative

Oct. 24, 1997

Cellular target of new antitumor agent from Nippon Shinyaku identified

Oct. 24, 1997

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

New DC-107 derivative presented at cancer meeting

Oct. 24, 1997

New antimitotic agents presented by Kyowa Hakko

Oct. 24, 1997

New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity

Oct. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...